Bayer's Xarelto® Shows Encouraging Results In Patients With Acute Coronary Syndrome

Secondary Prevention in Acute Coronary Syndrome (ACS): - - Phase II Data Presented as Late-Breaker at American Heart Association Meeting / Phase III Study to be Initiated in December 2008 - - Leverkusen… Read »